B cell-derived GABA elicits IL-10+ macrophages to limit anti-tumour immunity

Nature. 2021 Nov;599(7885):471-476. doi: 10.1038/s41586-021-04082-1. Epub 2021 Nov 3.

Abstract

Small, soluble metabolites not only are essential intermediates in intracellular biochemical processes, but can also influence neighbouring cells when released into the extracellular milieu1-3. Here we identify the metabolite and neurotransmitter GABA as a candidate signalling molecule synthesized and secreted by activated B cells and plasma cells. We show that B cell-derived GABA promotes monocyte differentiation into anti-inflammatory macrophages that secrete interleukin-10 and inhibit CD8+ T cell killer function. In mice, B cell deficiency or B cell-specific inactivation of the GABA-generating enzyme GAD67 enhances anti-tumour responses. Our study reveals that, in addition to cytokines and membrane proteins, small metabolites derived from B-lineage cells have immunoregulatory functions, which may be pharmaceutical targets allowing fine-tuning of immune responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B-Lymphocytes / immunology
  • B-Lymphocytes / metabolism*
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / metabolism
  • Cell Proliferation
  • Female
  • Gene Deletion
  • Glutamate Decarboxylase / deficiency
  • Glutamate Decarboxylase / genetics
  • Humans
  • Inflammation / immunology
  • Inflammation / prevention & control
  • Interleukin-10 / immunology*
  • Macrophages / immunology
  • Macrophages / metabolism*
  • Male
  • Mice
  • Neoplasms / immunology*
  • Neoplasms / pathology
  • T-Lymphocytes, Cytotoxic / immunology
  • T-Lymphocytes, Cytotoxic / metabolism
  • gamma-Aminobutyric Acid / biosynthesis
  • gamma-Aminobutyric Acid / metabolism*

Substances

  • IL10 protein, human
  • Interleukin-10
  • gamma-Aminobutyric Acid
  • Glutamate Decarboxylase
  • glutamate decarboxylase 1